Should You Buy Arcosa Inc (ACA) Today? Analysis, Price Targets, and 2026 Outlook.
Conclusion
Buy
Latest Price
113.050
1 Day change
-1.20%
52 Week Range
118.830
Analysis Updated At
2026/01/28
BUY for a beginner long-term investor right now. ACA is in a clear uptrend (bullish moving-average stack SMA_5 > SMA_20 > SMA_200) with neutral RSI (not overheated) and strong recent quarterly growth (2025/Q3 revenue +24.58% YoY; EPS +338.24% YoY). With no negative news flow and neutral-but-supportive options positioning, the current pre-market area (~113.51) near the pivot (114.118) is a reasonable entry for an impatient long-term buyer.
Technical Analysis
Trend: Bullish. The moving averages are positively stacked (SMA_5 > SMA_20 > SMA_200), which supports a sustained uptrend.
Momentum: MACD histogram is positive (0.0796) but contracting, suggesting the uptrend is intact while near-term momentum is cooling (more consolidation than immediate breakout).
RSI: RSI_6 at 54.946 is neutral—no clear overbought/oversold condition, which is favorable for initiating a long-term position without chasing an extreme.
Key levels: Pivot 114.118 is the near-term "line in the sand." Upside resistance levels are R1 117.794 and R2 120.066. Supports are S1 110.441 and S2 108.169.
Intellectia Proprietary Trading Signals:
**Intellectia Proprietary Trading Signals**
- [AI Stock Picker](module://ai_stock_pick): No signal on given stock today.
- [SwingMax](module://swingmax): No signal on given stock today.
Pattern-based short-horizon stats provided: next day expected move is slightly negative on average (-0.92%) with modestly positive 1-month bias (+1.27%), consistent with a bullish trend that can still chop short-term.
Options Data
Bullish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio
Options sentiment (2025-11-19 snapshot, price reference ~114.42):
- Open interest put/call ratio = 0.87 (more calls than puts outstanding) → mildly bullish positioning.
- Volume put/call ratio = 0.0 (7 calls traded, 0 puts) → bullish but based on very light volume.
- IV context: 30D IV 32.67 vs historical volatility 36.63; IV percentile 41.2 and IV rank 7.59 → options are not priced for extreme moves; sentiment looks steady rather than euphoric.
Overall: Options data leans mildly bullish/constructive, but liquidity/volume is low, so conviction from options flow is limited.
Technical Summary
Sell
4
Buy
7
Positive Catalysts
1) Strong operating momentum shown in the latest reported quarter (2025/Q3) with large YoY profitability improvement.
2) Technical setup remains bullish (trend-followers tend to support stocks with a strong moving-average stack).
3) Next earnings: 2026-02-25 (after hours). If momentum continues, this can act as a sentiment catalyst into the print.
Neutral/Negative Catalysts
1) Near-term momentum is cooling (MACD histogram positive but contracting), which can mean consolidation around ~114 before another leg higher.
2) No news catalysts in the past week; absent fresh headlines, the stock may drift/consolidate rather than surge.
3) Options trading volume is very light, limiting how much "sentiment" can be inferred from options flow.
Financial Performance
Latest quarter: 2025/Q3.
- Revenue: $797.8M, up 24.58% YoY (strong top-line acceleration).
- Net income: $73.0M, up 339.76% YoY (major profitability expansion).
- EPS: $1.49, up 338.24% YoY (strong per-share earnings growth).
- Gross margin: 24.05%, up 12.65% YoY (better mix/pricing and/or operating leverage).
Takeaway: Growth and margin expansion are strong, supporting a long-term buy case.
Growth
Profitability
Efficiency
Analyst Ratings and Price Target Trends
Recent analyst activity in the provided feed is mixed in relevance:
- For Arcosa specifically: Barclays (2025-11-03) raised its price target to $115 from $106 and kept an Overweight rating, citing stronger barge and wind orders in Q3.
- Two other items in the feed reference Credit Agricole (not Arcosa) and are not applicable to ACA.
Wall Street pros view (based on the relevant Arcosa note): Positive bias—order strength and raised PT support the bull case. Cons: Limited breadth of recent analyst updates in the provided data, so sentiment confirmation is narrow.
Holdings/flow context: Hedge funds neutral and insiders neutral (no notable recent buying/selling trends). Politician/congress trading: no recent congress trading data available (no signal from influential-figure transactions).
Wall Street analysts forecast ACA stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for ACA is 110 USD with a low forecast of 110 USD and a high forecast of 110 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
2 Analyst Rating
Wall Street analysts forecast ACA stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for ACA is 110 USD with a low forecast of 110 USD and a high forecast of 110 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
2 Buy
0 Hold
0 Sell
Moderate Buy
Current: 114.420
Low
110
Averages
110
High
110
Current: 114.420
Low
110
Averages
110
High
110
Deutsche Bank
Buy
maintain
AI Analysis
2026-01-21
Reason
Deutsche Bank
Price Target
AI Analysis
2026-01-21
maintain
Buy
Reason
Deutsche Bank raised the firm's price target on Credit Agricole to EUR 20 from EUR 19 and keeps a Buy rating on the shares.
RBC Capital
Anke Reingen
Sector Perform
maintain
$18 -> $19
2025-12-19
Reason
RBC Capital
Anke Reingen
Price Target
$18 -> $19
2025-12-19
maintain
Sector Perform
Reason
RBC Capital analyst Anke Reingen raised the firm's price target on Credit Agricole to C$19 from C$18 and keeps a Sector Perform rating on the shares.
Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for ACA
